Noa Biran of the John Theurer Cancer Center discussed some of the recent breakthroughs and new treatments that could help those with multiple myeloma, writes Brielle Urciuoli for Cure magazine.
Recent tests of triplet regimens (combinations of three drugs) proved helpful to a number of patients, especially those with poor prognoses. The new drug Xgeva, which can be used on patients with reduced renal function, has also proved beneficial to some patients. Chimeric antigen receptor T-cell therapy is another promising new treatment.
